POWELL FRED M (Executive Vice President & CFO) received a stock award from ANTARES PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2022ACC: 0001016169-22-000033
Officer· Executive Vice President & CFO
Since Jun 2019
+16.27K
Net shares
Net buyer
$43.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
27.78K acquired · 11.51K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.78K
Price / share
—
Trade value
—
% of position
3.6%
3/3/2022
774.76K→802.54K
Common Stock
Direct
Shares
−11.51K
Price / share
$3.80
Trade value
$43.72K
% of position
1.4%
3/3/2022
802.54K→791.04K
Total
Net shares
+16.27K
Net value
-$43.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2022 | A · Award | +27.78K | — | — | 3.6% | 774.76K | 802.54K |
| Common Stock Direct | 3/3/2022 | F · Tax Withholding | −11.51K | $3.80 | $43.72K | 1.4% | 802.54K | 791.04K |
| Total | +16.27K | -$43.72K | ||||||
Derivative Transactions0
No derivative transactions reported